中药干预治疗良性前列腺增生58例临床疗效观察

The clinical observation of traditional Chinese medicine in the treatment of 58 patients with benign prostatic hyperplasia

目的探讨中药治疗良性前列腺增生的临床疗效及不良反应。方法将58例良性前列腺增生患者根据治疗方法不同分为对照组(n=25)和中药干预组(n=33)。比较两组患者治疗前后临床观察指标的变化情况。结果两组治疗后国际前列腺症状评分(IPSS)评分、残余尿量、前列腺体积均明显降低,最大尿流率明显增加,与治疗前比较差异有统计学意义(P<0.05或P<0.01);中药干预组治疗后临床症状改善更加明显,与A组治疗后比较IPSS评分、残余尿量、前列腺体积均明显降低(P<0.01),最大尿流率明显增加(P<0.01)。中药干预组不良反应发生率明显低于对照组。结论中药干预治疗良性前列腺增生临床疗效明显,安全可靠。

Objective To explore the clinical efficacy and adverse reactions about traditional Chinese medicine treatment of benign prostatic hyperplasia.Methods Fifty-eight cases of benign prostatic hyperplasia patients under treatment were divided into control group（n=25） and the Chinese medicine intervention group（n=33）.Before and after treatment,some clinical indicators in these two groups were compared.Results After treatment,IPSS score,residual urine volume and prostate volume were significantly decreased,and maximum flow rate increased significantly（P0.05 or P0.01）.After treatment,clinical symptoms improvement was more obvious in group B compared with group A,IPSS score,residual urine volume,prostate volume decreased significantly（P0.01）,and maximum urinary flow rate increased significantly（P0.01）.The incidence of adverse reactions in intervention group was significantly lower than the control group.Conclusion Intervention with traditional Chinese medicine for benign prostatic hyperplasia has clinical efficacy and proves to be safe and reliable.